Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,064
Closed -$366K 276
2025
Q1
$366K Buy
3,064
+80
+3% +$9.91K 0.19% 146
2024
Q4
$346K Sell
2,984
-126
-4% -$15.9K 0.17% 162
2024
Q3
$420K Sell
3,110
-935
-23% -$125K 0.22% 143
2024
Q2
$549K Buy
4,045
+13
+0.3% +$1.77K 0.27% 108
2024
Q1
$521K Sell
4,032
-3,412
-46% -$412K 0.32% 96
2023
Q4
$851K Buy
+7,444
New +$743K 0.4% 88

Other funds holding XYL

Everpar Advisors's XYL Position: Q2 2025 in Review

Everpar Advisors sold out of Xylem (XYL) in Q2 2025, closing a stake of 3,064 shares — an estimated $366K sold.

Everpar Advisors first reported a position in XYL in Q4 2023 and held it in 6 quarters. The position peaked at $851K in Q4 2023. 1,063 funds tracked by Wall St. Rank hold XYL as of Q2 2025.

  • Everpar Advisors reported no remaining Xylem position as of Q2 2025 after selling out during the quarter.
  • Everpar Advisors sold 3,064 Xylem shares in Q2 2025, an estimated $366K.
  • Everpar Advisors first reported a position in Xylem in Q4 2023 and held it in 6 quarters.
  • Everpar Advisors's Xylem position peaked at $851K in Q4 2023.
  • 1,063 funds tracked by Wall St. Rank held Xylem as of Q2 2025.

Based on Everpar Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.